Cargando…
Erratum: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049913/ https://www.ncbi.nlm.nih.gov/pubmed/32057258 http://dx.doi.org/10.1164/rccm.v201erratum2 |
Ejemplares similares
-
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
por: Nahid, Payam, et al.
Publicado: (2019) -
ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?
por: Chang, Kwok-Chiu, et al.
Publicado: (2020) -
Erratum: Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
Publicado: (2021) -
Modified IDSA/ATS minor criteria for severe community-acquired pneumonia best predicted mortality: Erratum
Publicado: (2017) -
What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
por: Sharma, Surendra Kumar, et al.
Publicado: (2021)